Target intelligence / Profile preview

RNA component of mitochondrial RNA processing endoribonuclease pseudogene 5 (RMRPP5)

Target: RMRPP5
Molecular classification: Other

Overview

RNA component of mitochondrial RNA processing endoribonuclease pseudogene 5 (RMRPP5) is a human pseudogene, as classified by multiple authoritative resources, including HGNC (HGNC:47035) and GeneCards[4][6][8]. It is not a protein-coding gene and does not encode a functional receptor, enzyme, transporter, or any conventional therapeutic target. There are no known biological functions, disease associations, drug interactions, or relevant roles for biomarkers or safety. Its designation as a pseudogene (non-functional genomic locus similar to known genes) means it is not considered a therapeutic or druggable target[4][6][8].

Other names: RMRPP5

Beyond the preview

Go deeper on RNA component of mitochondrial RNA processing endoribonuclease pseudogene 5 (RMRPP5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA component of mitochondrial RNA processing endoribonuclease pseudogene 5 (RMRPP5).

Explore the full profile